Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic Medicine Sweden: Advancing precision medicine at the national level.

Journal of internal medicine·2026
Same author

Experimental observation of counter-intuitive features of photonic bunching.

Light, science & applications·2026
Same author

Accessory Soleus Muscle and Persistent Posterior Ankle Pain: Report of Three Cases.

Annali italiani di chirurgia·2026
Same author

Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis.

Nature genetics·2026
Same author

Spatial Multiomics Reveal Insights Into ADC Efficacy.

European journal of immunology·2026
Same author

Intragraft clonal expansion of cytotoxic CD8<sup>+</sup> and CD4<sup>+</sup> T cells in antibody-mediated kidney transplant rejection.

Kidney international·2026

Related Experiment Video

Updated: Dec 28, 2025

Mining Spatial Transcriptomics Datasets using DeepSpaceDB
10:16

Mining Spatial Transcriptomics Datasets using DeepSpaceDB

Published on: September 5, 2025

571

A Functional Landscape of CKD Entities From Public Transcriptomic Data.

Ferenc Tajti1,2, Christoph Kuppe2, Asier Antoranz3,4

  • 1Faculty of Medicine, RWTH Aachen University, Joint Research Centre for Computational Biomedicine (JRC-COMBINE), Aachen, Germany.

Kidney International Reports
|February 12, 2020
PubMed
Summary

Understanding chronic kidney disease (CKD) molecular mechanisms is key for new therapies and biomarkers. This study integrates gene expression data from nine CKD types, revealing distinct molecular signatures and potential drug targets like nilotinib.

Keywords:
CKDdrug repositioningsignaling pathwaytranscription factor

More Related Videos

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.0K
Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue
05:46

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue

Published on: June 9, 2020

4.3K

Related Experiment Videos

Last Updated: Dec 28, 2025

Mining Spatial Transcriptomics Datasets using DeepSpaceDB
10:16

Mining Spatial Transcriptomics Datasets using DeepSpaceDB

Published on: September 5, 2025

571
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.0K
Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue
05:46

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue

Published on: June 9, 2020

4.3K

Area of Science:

  • Genomics
  • Nephrology
  • Bioinformatics

Background:

  • Understanding molecular mechanisms of chronic kidney disease (CKD) is crucial for developing therapies and biomarkers.
  • Gene expression differences across various CKD origins require investigation.
  • Publicly available human glomerular gene expression data for nine prevalent CKD entities were utilized.

Purpose of the Study:

  • To investigate how gene expression profiles differ based on the origin of chronic kidney disease (CKD).
  • To demonstrate the potential of data analysis and integration for the nephrology research community.
  • To identify potential therapeutic targets and biomarkers for CKD.

Main Methods:

  • Integrated gene expression data from five public studies comparing diseased kidney glomeruli with control tissues.
  • Employed a stringent data integration procedure to harmonize data from diverse sources, platforms, and conditions.
  • Utilized transcriptome-wide analysis to delineate similarities and differences between kidney disease entities.

Main Results:

  • Generated a transcriptomic map illustrating the similarities and differences between nine kidney disease entities.
  • Identified key signaling pathways, transcription factors (e.g., FOXM1), and potential drug candidates (e.g., nilotinib) based on gene expression signatures.
  • Validated findings, such as specific FOXM1 expression in rapidly progressive glomerulonephritis (RPGN), using immunostaining.

Conclusions:

  • The study provides a foundation for understanding CKD molecular mechanisms, aiding biomarker and therapeutic target discovery.
  • An interactive web application was developed to share the integrated results and facilitate further research.
  • Emphasizes the value of functional genomics and data integration in nephrology research, while advising caution due to data limitations.